Skip to main content
PT Diagnos Laboratorium Utama Tbk logo

PT Diagnos Laboratorium Utama Tbk — Investor Relations & Filings

Ticker · DGNS ISIN · ID1000158702 IDX Human health and social work activities
Open in API
Filings indexed 13 across all filing types
Latest filing 2026-05-18 Regulatory Filings
Country ID Indonesia
Listing IDX DGNS

About PT Diagnos Laboratorium Utama Tbk

https://diagnos.co.id/

PT Diagnos Laboratorium Utama Tbk provides comprehensive health services through its laboratories. As part of the Bundamedik Healthcare System, the company offers a wide range of integrated clinical and genomic laboratory tests, including general health screenings, specialized diagnostics for infectious diseases, cancer risk assessment, and advanced genetic analyses like DNA and gut microbiota profiling. Services encompass medical check-ups, doctor consultations, and convenient homecare options, utilizing advanced technology to deliver fast, accurate, and reliable results for individuals and corporate clients.

Recent filings

Filing Released Lang Actions
Penjelasan atas Volatilitas Transaksi
Regulatory Filings Classification · 92% confidence The document is a formal letter from PT Diagnos Laboratorium Utama Tbk responding to a request by the Indonesia Stock Exchange for an explanation of unusually volatile trading. It outlines compliance with disclosure regulations (POJK), answers questions on material facts, shareholding activities, and corporate actions. It is not a financial report or management presentation, nor a dividend, merger, or board change notice. It is a miscellaneous regulatory disclosure filing and thus best fits the Regulatory Filings category (RNS).
2026-05-18 Indonesian
Penyampaian Bukti Iklan Pengumuman Rapat Umum Pemegenag Saham Tahunan dan Luar Biasa
Regulatory Filings Classification · 90% confidence The document is a short, formal announcement (“bukti iklan”) providing proof that the company has published notices of its Annual and Extraordinary General Meetings of Shareholders on various media. It contains no financial statements, proxy materials, or meeting presentations, nor does it request shareholder votes or report voting results. It does not itself constitute an AGM presentation, earnings release, or financial report but is a routine regulatory announcement under Indonesian exchange rules. Therefore, it falls under the general "Regulatory Filings" category.
2026-05-15 Indonesian
Pemanggilan Rapat Umum Pemegang Saham Tahunan dan Luar Biasa
Proxy Solicitation & Information Statement Classification · 87% confidence The document is an official invitation (‘Pemanggilan RUPS’) to convene both the Annual and Extraordinary General Meetings of Shareholders, detailing the date, recording date, venue, and agendas for approval and voting. It is pre‐meeting materials provided to shareholders to inform and solicit their attendance and votes. This aligns with the definition of Proxy Solicitation & Information Statement (PSI).
2026-05-13 Indonesian
Penambahan Modal Tanpa HMETD Hasil Pelaksanaan Penambahan Modal Tanpa HMETD
Share Issue/Capital Change Classification · 94% confidence The document provides detailed information on the result of a capital increase without preemptive rights by PT Diagnos Laboratorium Utama Tbk, including the number of shares issued, issue price, meeting date, and other terms—this is a clear announcement of a new share issuance/capital change.
2026-05-08 Indonesian
Laporan Bulanan Registrasi Pemegang Efek
Regulatory Filings Classification · 87% confidence The document is a routine monthly Securities Holders Registration Report (“Laporan Bulanan Registrasi Pemegang Efek”) disclosing holdings, classifications, free float and shareholder counts as of April 2026. It does not contain financial statements or voting results, nor is it a proxy statement, share issue notice or earnings release. It is a regulatory compliance submission of holder data to the exchange. As such, it falls under the generic Regulatory Filings category (RNS).
2026-05-08 Indonesian
Pencatatan Saham
Share Issue/Capital Change Classification · 90% confidence The document is an official stock exchange announcement from PT Bursa Efek Indonesia detailing the listing of new shares issued without preemptive rights, including number of shares, listing date, nominal value, and exercise price. This matches the description for Share Issue/Capital Change (announcements of new share issues or capital changes).
2026-05-07 Indonesian

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.